Identification of a N6-Methyladenosine (m6A)-Related lncRNA Signature for Predicting the Prognosis and Immune Landscape of Lung Squamous Cell Carcinoma

Overview of attention for article published in Frontiers in oncology, November 2021

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 13 Dimensions

Readers on

mendeley: 5 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 13 publications that cite this research output.

13

The most recent citing publications are shown below. View all 13 publications that cite this research output on Dimensions.

Tumor microenvironment characteristics and prognostic role of m6A modification in lung squamous cell carcinoma

Article in Heliyon (February 2024)

Establishment of a prognosis prediction model for lung squamous cell carcinoma related to PET/CT: basing on immunogenic cell death-related lncRNA

Article in BMC Pulmonary Medicine (December 2023)

Non-coding RNA-Mediated N6-Methyladenosine (m6A) deposition: A pivotal regulator of cancer, impacting key signaling pathways in carcinogenesis and therapy response

Article in Non-coding RNA Research (November 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.